摘要 |
<p>The present invention refers to an isolated anti-angiogenic peptide or a recombinant protein comprising the anti-angiogenic peptide, wherein the peptide is between 11 and 40 amino acids in length and having anti-angiogenic activity, the peptide comprising the amino acid sequence:
X1-X2-X3-X4-X5-X6-X7-X8-X9-X10-X11-X12-X13-X14,
wherein X1 is any amino acid residue compatible with forming a helix; X2 is an amino acid residue of: Leu, Ile, Val; X3 is an amino acid residue of: Arg, Lys, His, Ser, Thr; X4 is an amino acid residue of: Ile, Leu, Val; X5 is any amino acid residue compatible with forming a helix; X6 is an amino acid residue of: Leu, Ile, Val; X7 is an amino acid residue of: Leu, Ile, Val, Ser, Thr; X8 is any amino acid residue compatible with forming a helix; X9 is any amino acid residue compatible with forming a helix; X10 is an amino acid residue of: Gin, Glu, Asp, Arg, His, Lys, Asn; X11 is an amino acid residue of: Ser, Thr; X12 is an amino acid residue of: Trp, Tyr, Phe; X13 is an amino acid residue of: Leu, Ile, Val, Asn, Gin; X14 is an amino acid residue of: Glu, Gin, Asp, Asn.</p> |
申请人 |
UNIVERSITE DE LIEGE;FACULTE UNIVERSITAIRE DES SCIENCES AGRONOMIQUES DE GEMBLOUX |
发明人 |
MARTIAL, JOSEPH;STRUMAN, INGRID;NGUYEN, NGOC-QUYNH-NHU;BRASSEUR, ROBERT;LINS, LAURENCE |